Janda Kim 5
5 · Sorrento Therapeutics, Inc. · Filed Feb 6, 2023
Insider Transaction Report
Form 5
Janda Kim
Director
Transactions
- Sale
Common Stock
2021-03-15$10.42/sh−3,000$31,273→ 0 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.